A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer

Space Energy and Environment · Elsevier

Abstract

Publication date: 1 January 2027 Source: European Journal of Pharmaceutical Sciences, Volume 228 Author(s): Pouya Namakshenas, Roxan F.C.P.A. Helderman, Wim Ceelen, H. Petra Kok, Johannes Crezee

Read at publisher →

Similar articles